<DOC>
	<DOCNO>NCT02413450</DOCNO>
	<brief_summary>Human induce pluripotent stem cell ( hiPSCs ) drive paradigm shift model human disease ; ability reprogram patient-specific cell hold promise enhance understanding disease mechanism phenotypic variability , application personalize predictive pharmacology/toxicology , cell therapy regenerative medicine . This research collect blood skin biopsy patient healthy control purpose generate cell tissue model Mendelian heritable form heart disease focus cardiomyopathy , channelopathies neuromuscular disease . Cardiomyocytes derive hiPSCs provide ready source disease specific cell study pathogenesis therapeutic .</brief_summary>
	<brief_title>Derivation Human Induced Pluripotent Stem ( iPS ) Cells Heritable Cardiac Arrhythmias</brief_title>
	<detailed_description>Further study detail provide Gordon F. Tomaselli , Johns Hopkins University : Biospecimen Retention : Blood tissue sample , hiPSCs cardiomyocytes reprogrammed hiPSCs Eligible patient approach study explain full part obtain informed consent study . The subject opportunity ask question study . Control subject , often exclusively family member meet eligibility criterion undergo similar procedure inform consent . Subjects evaluate clinic 1-3 mm skin biopsy blood draw ( 30 cc ) . The subject ask medical history clinic visit information transmit research laboratory iPSCs generate re-programmed , disease genotype associate sample . The sample frozen store whole blood , white blood cell , skin biopsy , hiPSCs reprogrammed cardiomyocytes .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Cardiomyopathy , Dilated</mesh_term>
	<mesh_term>Cardiomyopathy , Hypertrophic</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<mesh_term>Myotonic Dystrophy</mesh_term>
	<mesh_term>Arrhythmias , Cardiac</mesh_term>
	<mesh_term>Long QT Syndrome</mesh_term>
	<mesh_term>Brugada Syndrome</mesh_term>
	<criteria>All patient family member 18 year age older inherit cardiac arrhythmia include LQTS , Brugada Syndrome ( BrS ) , cathecholaminergic polymorphic ventricular tachycardia ( CPVT ) early repolarization syndrome ( ERS ) eligible enrollment . All enrol patient undergone clinically indicate genetic testing . Age &lt; 18 year &gt; 85 year pregnant woman lifelimiting comorbidities immunocompromise</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>induced Pluripotent Stem Cells ( iPSC )</keyword>
	<keyword>Channelopathies</keyword>
	<keyword>Catecholaminergic</keyword>
	<keyword>Arrhythmogenic</keyword>
</DOC>